Patents by Inventor Ebenezer Satyaraj
Ebenezer Satyaraj has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230399389Abstract: Compositions suitable for reducing symptoms of an allergic response to environmental allergens comprising molecules that specifically inhibit the ability of the allergen to bind to mast cells in an animal predisposed to having an allergic response to the allergen and methods for reducing such symptoms comprising contacting a source of the environmental allergen with such compositions. Kits, packages, medicaments, and means of communicating about the compositions and methods are also provided.Type: ApplicationFiled: August 25, 2023Publication date: December 14, 2023Inventors: George Wells, Ebenezer Satyaraj
-
Patent number: 11649278Abstract: Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.Type: GrantFiled: August 10, 2020Date of Patent: May 16, 2023Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.Inventors: Timothy James Wooster, Ebenezer Satyaraj, Eddy Gombas, Beat Gerber
-
Patent number: 11641842Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.Type: GrantFiled: June 9, 2021Date of Patent: May 9, 2023Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.Inventors: Ebenezer Satyaraj, Peichuan Sun, Scott Sherrill, Qinghong Li, Steven Hannah
-
Publication number: 20210289739Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.Type: ApplicationFiled: June 9, 2021Publication date: September 23, 2021Inventors: Ebenezer Satyaraj, Peichuan Sun, Scott Sherrill, Qinghong Li, Steven Hannah
-
Patent number: 11102952Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.Type: GrantFiled: May 21, 2018Date of Patent: August 31, 2021Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.Inventors: Ebenezer Satyaraj, Peichuan Sun, Scott Sherrill, Qinghong Li, Steven Hannah
-
Patent number: 10889785Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.Type: GrantFiled: April 4, 2018Date of Patent: January 12, 2021Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.Inventors: George Wells, Delphine Tissot-Favre, Ebenezer Satyaraj, Juergen Eck, Daniel Meyer, Torsten Ertongur-Fauth, Alexander Pelzer, Scott Sherrill, Peichuan Sun
-
Publication number: 20200392218Abstract: Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.Type: ApplicationFiled: August 10, 2020Publication date: December 17, 2020Inventors: Timothy James Wooster, Ebenezer Satyaraj, Eddy Gombas, Beat Gerber
-
Patent number: 10774137Abstract: Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.Type: GrantFiled: January 18, 2018Date of Patent: September 15, 2020Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.Inventors: Timothy James Wooster, Ebenezer Satyaraj, Eddy Gombas, Beat Gerber
-
Publication number: 20190023772Abstract: Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.Type: ApplicationFiled: January 18, 2018Publication date: January 24, 2019Inventors: Timothy James Wooster, Ebenezer Satyaraj, Eddy Gombas, Beat Gerber
-
Publication number: 20180338467Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.Type: ApplicationFiled: May 21, 2018Publication date: November 29, 2018Inventors: Ebenezer Satyaraj, Peichuan Sun, Scott Sherrill, Qinghong Li, Steven Hannah
-
Publication number: 20180223223Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.Type: ApplicationFiled: April 4, 2018Publication date: August 9, 2018Inventors: George Wells, Delphine Tissot-Favre, Ebenezer Satyaraj, Juergen Eck, Daniel Meyer, Torsten Ertongur-Fauth, Alexander Pelzer, Scott Sherrill, Peichuan Sun
-
Patent number: 10010566Abstract: The invention provides methods and compositions useful for ameliorating age related maladies, enhancing and maintaining immune function, enhancing and maintaining cognitive function, enhancing and maintaining muscle strength, enhancing and maintaining balance, and reducing and mitigating oxidative stress in an animal. The compositions comprise a combination of at least two of one or more unsaturated fatty acids (UFA); one or more nitric oxide releasing compounds (NORC); one or more anti-glycation agents; and colostrum, and the methods comprise administering to an animal a therapeutically effective amount of the compositions.Type: GrantFiled: March 12, 2012Date of Patent: July 3, 2018Assignee: NestecSAInventor: Ebenezer Satyaraj
-
Publication number: 20160289312Abstract: Compositions suitable for reducing symptoms of an allergic response to environmental allergens comprising molecules that specifically inhibit the ability of the allergen to bind to mast cells in an animal predisposed to having an allergic response to the allergen and methods for reducing such symptoms comprising contacting a source of the environmental allergen with such compositions. Kits, packages, medicaments, and means of communicating about the compositions and methods are also provided.Type: ApplicationFiled: June 14, 2016Publication date: October 6, 2016Inventors: George Wells, Ebenezer Satyaraj
-
Patent number: 9388236Abstract: Compositions suitable for reducing symptoms of an allergic response to environmental allergens comprising molecules that specifically inhibit the ability of the allergen to bind to mast cells in an animal predisposed to having an allergic response to the allergen and methods for reducing such symptoms comprising contacting a source of the environmental allergen with such compositions. Kits, packages, medicaments, and means of communicating about the compositions and methods are also provided.Type: GrantFiled: April 25, 2013Date of Patent: July 12, 2016Assignee: Nestec SAInventors: George Wells, Ebenezer Satyaraj
-
Publication number: 20150175940Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.Type: ApplicationFiled: December 15, 2014Publication date: June 25, 2015Inventors: George Wells, Delphine Tissot-Favre, Ebenezer Satyaraj, Juergen Eck, Daniel Meyer, Torsten Ertongur-Fauth, Alexander Pelzer, Scott Sherrill, Peichuan Sun
-
Publication number: 20140136118Abstract: The invention provides methods and devices for evaluating and tracking canine physical activity by determining for a canine (1) the duration of an activity or exercise; the speed of the activity or exercise based on the type of activity or exercise pace, e.g., walking, trotting, cantering, or running; a breed category factor to accommodate speed differences in distance travelled because of differences in body size and stride length; and an age factor and (2) calculating physical activity points (PAP) for the canine using an equation designed to accept input for the variables in (1) and use those variables to calculate PAP. The results from the equation are used to evaluate the physical activity of the canine and, based upon the evaluation, alter, if required, the canine's physical activity in a way that benefits the canine, particularly the canine's health.Type: ApplicationFiled: November 11, 2013Publication date: May 15, 2014Applicant: NESTEC SAInventors: Brian Michael Zanghi, Robert Tochterman, Shawn Brain, Arleigh Reynolds, Steven S. Hannah, Ebenezer Satyaraj
-
Publication number: 20140004205Abstract: The invention provides methods and compositions useful for ameliorating age related maladies, enhancing and maintaining immune function, enhancing and maintaining cognitive function, enhancing and maintaining muscle strength, enhancing and maintaining balance, and reducing and mitigating oxidative stress in an animal. The compositions comprise a combination of at least two of one or more unsaturated fatty acids (UFA); one or more nitric oxide releasing compounds (NORC); one or more anti-glycation agents; and colostrum, and the methods comprise administering to an animal a therapeutically effective amount of the compositions.Type: ApplicationFiled: March 12, 2012Publication date: January 2, 2014Applicant: Nestec SAInventor: Ebenezer Satyaraj
-
Patent number: 8454953Abstract: Compositions suitable for reducing symptoms of an allergic response to environmental allergens comprising molecules that specifically inhibit the ability of the allergen to bind to mast cells in an animal predisposed to having an allergic response to the allergen and methods for reducing such symptoms comprising contacting a source of the environmental allergen with such compositions. Kits, packages, medicaments, and means of communicating about the compositions and methods are also provided.Type: GrantFiled: July 9, 2008Date of Patent: June 4, 2013Assignee: Nestec SAInventors: George Wells, Ebenezer Satyaraj
-
Publication number: 20120122717Abstract: Multiplex assays are provided including panels of probes for development of multiplex assays capable of simultaneously measuring multiple biologically-relevant proteins using very small quantities of biological samples to rapidly assess the health status of animals, especially companion animals, as well as to formulate nutritional regimens for improving the health status of animals. The probes are provided as are methods for using them to assess the health status of animals, as well as their responses to therapeutic or nutritional interventions therein.Type: ApplicationFiled: November 15, 2011Publication date: May 17, 2012Applicant: Nestec S.A.Inventors: Ebenezer Satyaraj, Steven S. Hannah
-
Publication number: 20100196880Abstract: Multiplex assays are provided including panels of probes for development of multiplex assays capable of simultaneously measuring multiple biologically-relevant proteins using very small quantities of biological samples to rapidly assess the health status of animals, especially companion animals, as well as to formulate nutritional regimens for improving the health status of animals. The probes are provided as are methods for using them to assess the health status of animals, as well as their responses to therapeutic or nutritional interventions therein.Type: ApplicationFiled: October 4, 2007Publication date: August 5, 2010Inventors: Ebenezer Satyaraj, Steven S. Hannah